CAS 13171-25-0
:Trimetazidine dihydrochloride
Description:
Trimetazidine dihydrochloride is a pharmaceutical compound primarily used as an antianginal agent, particularly in the management of stable angina pectoris. It functions by optimizing cellular metabolism, enhancing glucose utilization, and improving energy production in ischemic heart tissues. The substance is characterized by its chemical formula, which includes two hydrochloride ions, indicating its salt form. Trimetazidine is known for its ability to reduce the frequency and severity of angina attacks without affecting heart rate or blood pressure significantly. It is typically administered orally and is well-absorbed in the gastrointestinal tract. The compound exhibits a favorable safety profile, with side effects generally being mild and transient. Trimetazidine dihydrochloride is often prescribed in conjunction with other antianginal medications to provide a comprehensive approach to angina management. Its mechanism of action, primarily involving the modulation of fatty acid oxidation and promotion of glucose oxidation, makes it a unique therapeutic option in cardiovascular medicine.
Formula:C14H22N2O3·2ClH
InChI:InChI=1S/C14H22N2O3.2ClH/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16;;/h4-5,15H,6-10H2,1-3H3;2*1H
InChI key:InChIKey=VYFLPFGUVGMBEP-UHFFFAOYSA-N
SMILES:C(C1=C(OC)C(OC)=C(OC)C=C1)N2CCNCC2.Cl
Synonyms:- 1-(2,3,4-Trimethoxybenzyl)Piperazine
- 1-(2,3,4-Trimethoxybenzyl)Piperazine Dihydrochloride
- 1-(2,3,4-Trimethoxybenzyl)Piperazinediium
- 1-[(2,3,4-Trimethoxyphenyl)Methyl]Piperazine Dihydrochloride
- Kyurinett
- Piperazine, 1-(2,3,4-trimethoxybenzyl)-, dihydrochloride
- Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, dihydrochloride
- Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2)
- S 4004
- Trimetazidine 2HCl
- Trimetazidine Dihydrochloride
- Trivedon
- Vastarel
- Vastarel F
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Trimetazidine Dihydrochloride
CAS:Formula:C14H22N2O3·2HClPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:339.26Trimetazidine Dihydrochloride 1.0 mg/ml in Methanol (as free base)
CAS:Controlled ProductColor and Shape:Single SolutionTRIMETAZIDINE FOR SYSTEM SUITABILITY CRS
CAS:TRIMETAZIDINE FOR SYSTEM SUITABILITY CRSFormula:C14H24Cl2N2O3Color and Shape:RemovedMolecular weight:339.258Trimetazidine dihydrochloride
CAS:Trimetazidine, an anti-ischemic agent, enhances myocardial glucose use, inhibits fat metabolism, and helps with angina.Formula:C14H24Cl2N2O3Purity:99.58%Color and Shape:Crystalline SolidMolecular weight:339.258Trimetazidine DiHCl
CAS:Formula:C14H22N2O3·2HClColor and Shape:White To Off-White SolidMolecular weight:266.34 2*36.46Trimetazidine dihydrochloride
CAS:Controlled ProductFormula:C14H22N2O3ClHColor and Shape:NeatMolecular weight:339.26Trimetazidine Dihydrochloride
CAS:Controlled Product<p>Applications Coronary vasodilator. Antianginal.<br>References Fujita, et al.: Jpn. J. Pharmacol., 17, 19 (1967), Harpey, C., et al.: Cardiovasc. Drug Rev., 6, 292 (1989),<br></p>Formula:C14H22N2O3·2ClHColor and Shape:Off WhiteMolecular weight:339.26Trimetazidine dihydrochloride
CAS:Controlled Product<p>Trimetazidine dihydrochloride is a drug that has been shown to have statistically significant effects on mitochondrial functions. Trimetazidine is an anti-ischemic agent, which prevents myocardial infarcts by inhibiting the release of natriuretic peptides and thus reducing the level of intracellular cGMP. Trimetazidine dihydrochloride has also been shown to reduce cardiac hypertrophy and fibrosis, which are caused by oxidative stress and hypertension.</p>Formula:C14H22N2O3•(HCl)2Purity:Min. 95%Color and Shape:PowderMolecular weight:339.26 g/molPiperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2)
CAS:Formula:C14H24Cl2N2O3Color and Shape:SolidMolecular weight:339.2580










